Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14304 clinical trials
Featured trial
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Background: Chronic lymphocytic leukemia (CLL) is a cancer of white blood cells. It is also called small lymphocytic lymphoma (SLL). It causes tiredness, night sweats

TP53
fatigue
anemia
fludarabine
cancer
  • 359 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Response to the HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) tend to get infections more easily. This is because their immune

acalabrutinib
chronic lymphocytic leukemia
lymphoma
ibrutinib
  • 67 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

. Scientists had thought people with chronic lymphocytic leukemia (CLL) should not get the shingles vaccine. Now there is a new shingles vaccine that is not live and cannot cause shingles. The new shingles

ibrutinib
cancer
acalabrutinib
lymphoma
chronic lymphocytic leukemia
  • 238 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL/SLL), Lymphoplasmacytic Lymphoma(LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma(SMZL)

(MBL), chronic lymphocytic leukemia(CLL)/small lymphocytic lymphoma (SLL), lymphoplasmacytic lymphoma (LPL)/Waldenstrom macroglobulinemia (WM), and splenic marginal zone lymphoma (SMZL). Applying these

lymphocytosis
lymphadenopathy
cancer
lymphoma
marginal zone lymphoma
  • 115 views
  • 15 Apr, 2019
  • 1 location
Featured trial
A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Background: Chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL) are tumors of abnormal B cells that often affect elderly patients. Studies have

fatigue
anemia
fludarabine
lymphoma
thrombocytopenia
  • 169 views
  • 15 Apr, 2019
  • 1 location
Featured trial
Timeless: Tenecteplase in Stroke Patients Between 4.5 and 24 Hours

This study will evaluate the efficacy and safety of Tenecteplase compared with placebo in participants with acute ischemic stroke (AIS). All participants will receive standard-of-care therapy

stroke
  • 5 views
  • 18 May, 2022
  • 1 location
Featured trial
Asthma Research for Adolescents and Adults

North Carolina Clinical Research is enrolling adults and adolescents with asthma in a clinical research study. All subjects will receive an active inhaler to treat their asthma.

  • 18 views
  • 23 Mar, 2022
  • 1 location
Featured trial
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390

  • 2 views
  • 10 May, 2022
  • 2 locations
Featured trial
Cytomegalovirus Vaccine

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety and reactogenicity of mRNA-1647 vaccine in all

  • 0 views
  • 19 Jan, 2022
  • 1 location
Featured trial
Hives - H1100

and you will receive regular treatment and consultation. All participants will receive the actual treatment, there are no placebos in this trial.Compensation:- Compensation from up to $1300- Study

Accepts healthy volunteers
  • 17 views
  • 25 May, 2022
  • 1 location